























NxStage to Present at the 31st Annual J.P. Morgan Healthcare Conference
Published in Health and Fitness on Tuesday, December 18th 2012 at 5:16 GMT by Market Wire

NxStage to Present at the 31st Annual J.P. Morgan Healthcare Conference -- LAWRENCE, Mass., Dec. 18, 2012 /PRNewswire/ --
LAWRENCE, Mass., Dec. 18, 2012 /PRNewswire/ -- NxStage® Medical, Inc. (Nasdaq: [ NXTM ]), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank , Chief Executive Officer and Robert Brown , Chief Financial Officer, will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco, CA on January 8th at 4 p.m. PST.
(Logo: [ http://photos.prnewswire.com/prnh/20110503/MM94799LOGO ])
A webcast of the event will be made available at [ http://ir.nxstage.com ] at the time of the presentation.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: [ NXTM ]) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company's website at [ http://www.nxstage.com ].
Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Examples of these forward-looking statements include statements as to Messrs. Burbank and Brown's plans to present at this conference. NxStage specifically disclaims any obligation to update these forward-looking statements. These forward-looking statements should not be relied upon as representing NxStage's expectations or beliefs as of any date subsequent to the date of this press release.
Contact:
Kristen K. Sheppard, Esq.
Investor Relations
[ ksheppard@nxstage.com ]
SOURCE NxStage Medical, Inc.
RELATED LINKS
[ http://www.nxstage.com ]